Fexinidazole is a nitroimidazole derivative used as an oral antiparasitic and antimicrobial agent, primarily indicated for the treatment of human African trypanosomiasis, or sleeping sickness, caused by… Read more
Fexinidazole is a nitroimidazole derivative used as an oral antiparasitic and antimicrobial agent, primarily indicated for the treatment of human African trypanosomiasis, or sleeping sickness, caused by Trypanosoma brucei subspecies. This category contains a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds crucial for the development and testing of this medication. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and rigorous quality control protocols during the manufacturing process. By utilizing these precise analytical tools, researchers can ensure accurate quantification and identification of degradation products and metabolites, thereby supporting the regulatory compliance and therapeutic efficacy of the active pharmaceutical ingredient throughout its lifecycle in clinical applications.